S. Chèze

917 total citations
22 papers, 421 citations indexed

About

S. Chèze is a scholar working on Hematology, Genetics and Nephrology. According to data from OpenAlex, S. Chèze has authored 22 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 6 papers in Genetics and 3 papers in Nephrology. Recurrent topics in S. Chèze's work include Platelet Disorders and Treatments (6 papers), Blood groups and transfusion (6 papers) and Acute Myeloid Leukemia Research (5 papers). S. Chèze is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Blood groups and transfusion (6 papers) and Acute Myeloid Leukemia Research (5 papers). S. Chèze collaborates with scholars based in France, Luxembourg and India. S. Chèze's co-authors include Pierre Fenaux, François Dreyfus, Xavier Troussard, Aspasia Stamatoullas, Odile Beyne‐Rauzy, Lionel Adès, Stéphane Giraudier, Lionel Mannone, Claude Gardin and Dominique Bordessoule and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

S. Chèze

21 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Chèze France 12 322 203 81 53 43 22 421
Thibault Comont France 11 220 0.7× 145 0.7× 53 0.7× 87 1.6× 19 0.4× 54 464
S. D. Rowley United States 8 280 0.9× 128 0.6× 140 1.7× 139 2.6× 26 0.6× 11 436
Vittorio Fregoni Italy 11 173 0.5× 103 0.5× 35 0.4× 157 3.0× 43 1.0× 23 383
Henk Louwes Netherlands 8 358 1.1× 87 0.4× 81 1.0× 23 0.4× 25 0.6× 14 448
Marshall Mazepa United States 11 296 0.9× 86 0.4× 17 0.2× 44 0.8× 42 1.0× 33 449
Yoshio Kiyama Japan 10 172 0.5× 76 0.4× 42 0.5× 54 1.0× 20 0.5× 28 340
R Cimino Italy 10 424 1.3× 200 1.0× 40 0.5× 100 1.9× 18 0.4× 22 531
Hava Üsküdar Teke Türkiye 11 106 0.3× 56 0.3× 44 0.5× 39 0.7× 18 0.4× 53 273
Reggie Kelly United States 7 434 1.3× 94 0.5× 106 1.3× 11 0.2× 29 0.7× 9 473
Radha Raghupathy Hong Kong 9 106 0.3× 82 0.4× 35 0.4× 70 1.3× 9 0.2× 27 304

Countries citing papers authored by S. Chèze

Since Specialization
Citations

This map shows the geographic impact of S. Chèze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Chèze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Chèze more than expected).

Fields of papers citing papers by S. Chèze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Chèze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Chèze. The network helps show where S. Chèze may publish in the future.

Co-authorship network of co-authors of S. Chèze

This figure shows the co-authorship network connecting the top 25 collaborators of S. Chèze. A scholar is included among the top collaborators of S. Chèze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Chèze. S. Chèze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chèze, S., Stéphane Girault, Pascal Turlure, et al.. (2023). Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial. Leukemia Research. 129. 107058–107058. 6 indexed citations
2.
Maigné, G., Sylvain Chantepie, Anne‐Claire Gac, et al.. (2016). Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles. International Journal of Hematology. 104(1). 85–91. 14 indexed citations
3.
Cheminant, Morgane, Coralie Derrieux, Aurore Touzart, et al.. (2015). Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study. Haematologica. 101(3). 336–345. 43 indexed citations
4.
Blanchardière, A. de La, S. Chèze, D Arsène, et al.. (2014). Campylobacter coli cultured from the stools of a patient with immunoproliferative small intestinal disease. Clinical Microbiology and Infection. 20(9). 908–911. 9 indexed citations
5.
Boysson, Hubert de, Luc Darnige, Andrew D. Johnson, et al.. (2014). Syndrome des antiphospholides « séronégatif », syndrome catastrophique, nouveaux anticoagulants : enseignements d’une observation de prise en charge difficile. La Revue de Médecine Interne. 35(11). 752–756. 14 indexed citations
6.
Gerfaud‐Valentin, Mathieu, Matthieu Mahévas, Louis Terriou, et al.. (2014). Caractéristiques et modalités évolutives du purpura thrombopénique idiopathique multiréfractaire en 2014 : analyse de 26 observations. La Revue de Médecine Interne. 35. A86–A87. 1 indexed citations
7.
Khellaf, M., M. Hamidou, S. Chèze, et al.. (2013). A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia. Haematologica. 98(6). 881–887. 60 indexed citations
8.
Kelaïdi, Charikleia, Sophie Park, Rosa Sapena, et al.. (2013). Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents. Leukemia. 27(6). 1283–1290. 47 indexed citations
9.
10.
Khellaf, Mehdi, S. Chèze, François Lefrère, et al.. (2012). Intérêt de l’alternance des agonistes du récepteur de la thrombopoïetine (étude Switch) au cours du purpura thrombopénique immunologique. La Revue de Médecine Interne. 33. S59–S60. 1 indexed citations
11.
Park, Sophie, Rosa Sapena, Charikleia Kelaïdi, et al.. (2011). Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS. Leukemia Research. 35(11). 1530–1533. 16 indexed citations
12.
Gyan, Emmanuel, Valérie Andrieu‐Ponel, A. Caillé, et al.. (2011). 59 Myelodysplastic syndromes with isolated neutropenia or thrombocytopenia: Are they refractory cytopenias with unilineage dysplasia? A GFM registry study. Leukemia Research. 35. S22–S22. 1 indexed citations
13.
Aapro, Matti, et al.. (2011). Prise en charge initiale de la neutropénie fébrile. ONCOLOGIE. 13(12). 818–824. 1 indexed citations
14.
Renaudier, P., et al.. (2009). Complications pulmonaires de la transfusion (TACO–TRALI). Transfusion Clinique et Biologique. 16(2). 218–232. 18 indexed citations
15.
Renaudier, P., et al.. (2008). Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results. Transfusion Medicine and Hemotherapy. 35(2). 89–91. 6 indexed citations
16.
Mannone, Lionel, Claude Gardin, Jérôme Bernard, et al.. (2006). High‐dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study. British Journal of Haematology. 133(5). 513–519. 72 indexed citations
17.
Mannone, Lionel, Claude Gardin, J. F. Bernard, et al.. (2004). High Response Rate to Darbopoetin Alfa in “Low Risk” MDS : Results of a Phase II Study.. Blood. 104(11). 69–69. 11 indexed citations
18.
19.
Macro, Margaret, Isabelle André‐Schmutz, E. Comby, et al.. (1999). IgE Multiple Myeloma. Leukemia & lymphoma. 32(5-6). 597–603. 22 indexed citations
20.
Chèze, S., Oumédaly Reman, M. Vergnaud, et al.. (1994). Septicémie à Clostridium perfringens au cours d'une aplasie chimio-induite. La Revue de Médecine Interne. 15(9). 597–600.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thibault Comont Breakdown of academic impact, for papers by S. D. Rowley Breakdown of academic impact, for papers by Vittorio Fregoni Breakdown of academic impact, for papers by Henk Louwes Breakdown of academic impact, for papers by Marshall Mazepa Breakdown of academic impact, for papers by Yoshio Kiyama Breakdown of academic impact, for papers by R Cimino Breakdown of academic impact, for papers by Hava Üsküdar Teke Breakdown of academic impact, for papers by Reggie Kelly Breakdown of academic impact, for papers by Radha Raghupathy
Rankless by CCL
2026